Abstract
We examine simple mathematical models to investigate the circumstances under which the dynamics of cytotoxic T-lymphocyte (CTL) activation and differentiation may result in the loss of virus specific CD8+ cells, a process known as CTL exhaustion. We distinguish between two general classes of viruses: (i) viruses infecting cells that are not involved in the immune response; and (ii) viruses infecting antigen presenting cells (APCs) and helper cells. The models specify host and viral properties that lead to CTL exhaustion and indicate that this phenomenon is only likely to be observed with viruses infecting APCs and helper cells. Moreover, it is found that for such viruses, a high rate of replication and a low degree of cytopathogenicity promote the exhaustion of the CTL response. In addition, a high initial virus load and a low CD4+ cell count promote the occurrence of CTL exhaustion. These conclusions are discussed with reference to empirical data on lymphocytic choriomeningitis virus and on human immunodeficiency virus.
Full Text
The Full Text of this article is available as a PDF (814.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aebischer T., Moskophidis D., Rohrer U. H., Zinkernagel R. M., Hengartner H. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11047–11051. doi: 10.1073/pnas.88.24.11047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ahmed R., Oldstone M. B. Organ-specific selection of viral variants during chronic infection. J Exp Med. 1988 May 1;167(5):1719–1724. doi: 10.1084/jem.167.5.1719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Althage A., Odermatt B., Moskophidis D., Kündig T., Hoffman-Rohrer U., Hengartner H., Zinkernagel R. M. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur J Immunol. 1992 Jul;22(7):1803–1812. doi: 10.1002/eji.1830220720. [DOI] [PubMed] [Google Scholar]
- Asjö B., Morfeldt-Månson L., Albert J., Biberfeld G., Karlsson A., Lidman K., Fenyö E. M. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet. 1986 Sep 20;2(8508):660–662. [PubMed] [Google Scholar]
- Battegay M., Bachmann M. F., Burhkart C., Viville S., Benoist C., Mathis D., Hengartner H., Zinkernagel R. M. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain. Cell Immunol. 1996 Jan 10;167(1):115–121. doi: 10.1006/cimm.1996.0014. [DOI] [PubMed] [Google Scholar]
- Battegay M., Cooper S., Althage A., Bänziger J., Hengartner H., Zinkernagel R. M. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods. 1991 Jun;33(1-2):191–198. doi: 10.1016/0166-0934(91)90018-u. [DOI] [PubMed] [Google Scholar]
- Battegay M., Moskophidis D., Rahemtulla A., Hengartner H., Mak T. W., Zinkernagel R. M. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol. 1994 Jul;68(7):4700–4704. doi: 10.1128/jvi.68.7.4700-4704.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Battegay M., Moskophidis D., Waldner H., Bründler M. A., Fung-Leung W. P., Mak T. W., Hengartner H., Zinkernagel R. M. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J Immunol. 1993 Nov 15;151(10):5408–5415. [PubMed] [Google Scholar]
- Bertoletti A., Sette A., Chisari F. V., Penna A., Levrero M., De Carli M., Fiaccadori F., Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 1994 Jun 2;369(6479):407–410. doi: 10.1038/369407a0. [DOI] [PubMed] [Google Scholar]
- Borrow P., Evans C. F., Oldstone M. B. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol. 1995 Feb;69(2):1059–1070. doi: 10.1128/jvi.69.2.1059-1070.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borrow P., Lewicki H., Wei X., Horwitz M. S., Peffer N., Meyers H., Nelson J. A., Gairin J. E., Hahn B. H., Oldstone M. B. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med. 1997 Feb;3(2):205–211. doi: 10.1038/nm0297-205. [DOI] [PubMed] [Google Scholar]
- Borrow P., Tishon A., Oldstone M. B. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection. J Exp Med. 1991 Jul 1;174(1):203–212. doi: 10.1084/jem.174.1.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Connor R. I., Ho D. D. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol. 1994 Jul;68(7):4400–4408. doi: 10.1128/jvi.68.7.4400-4408.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dockter J., Evans C. F., Tishon A., Oldstone M. B. Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J Virol. 1996 Mar;70(3):1799–1803. doi: 10.1128/jvi.70.3.1799-1803.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Doherty P. C. Immune exhaustion: driving virus-specific CD8+ T cells to death. Trends Microbiol. 1993 Sep;1(6):207–209. doi: 10.1016/0966-842x(93)90133-c. [DOI] [PubMed] [Google Scholar]
- Evans C. F., Borrow P., de la Torre J. C., Oldstone M. B. Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence. J Virol. 1994 Nov;68(11):7367–7373. doi: 10.1128/jvi.68.11.7367-7373.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fenouillet E., Blanes N., Benjouad A., Gluckman J. C. Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity. Clin Exp Immunol. 1995 Mar;99(3):419–424. doi: 10.1111/j.1365-2249.1995.tb05567.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fenyö E. M., Morfeldt-Månson L., Chiodi F., Lind B., von Gegerfelt A., Albert J., Olausson E., Asjö B. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol. 1988 Nov;62(11):4414–4419. doi: 10.1128/jvi.62.11.4414-4419.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fenyö E. M., Putkonen P. Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections. Immunol Lett. 1996 Jun;51(1-2):95–99. doi: 10.1016/0165-2478(96)02561-8. [DOI] [PubMed] [Google Scholar]
- Ferbas J., Daar E. S., Grovit-Ferbas K., Lech W. J., Detels R., Giorgi J. V., Kaplan A. H. Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection. J Virol. 1996 Oct;70(10):7285–7289. doi: 10.1128/jvi.70.10.7285-7289.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fowlkes B. J., Ramsdell F. T-cell tolerance. Curr Opin Immunol. 1993 Dec;5(6):873–879. doi: 10.1016/0952-7915(93)90099-e. [DOI] [PubMed] [Google Scholar]
- Goulder P. J., Phillips R. E., Colbert R. A., McAdam S., Ogg G., Nowak M. A., Giangrande P., Luzzi G., Morgan B., Edwards A. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med. 1997 Feb;3(2):212–217. doi: 10.1038/nm0297-212. [DOI] [PubMed] [Google Scholar]
- Gruters R. A., Terpstra F. G., De Goede R. E., Mulder J. W., De Wolf F., Schellekens P. T., Van Lier R. A., Tersmette M., Miedema F. Immunological and virological markers in individuals progressing from seroconversion to AIDS. AIDS. 1991 Jul;5(7):837–844. doi: 10.1097/00002030-199107000-00007. [DOI] [PubMed] [Google Scholar]
- Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995 Jan 12;373(6510):123–126. doi: 10.1038/373123a0. [DOI] [PubMed] [Google Scholar]
- Jameson S. C., Bevan M. J. T cell receptor antagonists and partial agonists. Immunity. 1995 Jan;2(1):1–11. doi: 10.1016/1074-7613(95)90074-8. [DOI] [PubMed] [Google Scholar]
- Jameson S. C., Carbone F. R., Bevan M. J. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med. 1993 Jun 1;177(6):1541–1550. doi: 10.1084/jem.177.6.1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kalams S. A., Walker B. D. Cytotoxic T lymphocytes and HIV-1 related neurologic disorders. Curr Top Microbiol Immunol. 1995;202:79–88. doi: 10.1007/978-3-642-79657-9_6. [DOI] [PubMed] [Google Scholar]
- Karrer U., Althage A., Odermatt B., Roberts C. W., Korsmeyer S. J., Miyawaki S., Hengartner H., Zinkernagel R. M. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice. J Exp Med. 1997 Jun 16;185(12):2157–2170. doi: 10.1084/jem.185.12.2157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- King C. C., de Fries R., Kolhekar S. R., Ahmed R. In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection. J Virol. 1990 Nov;64(11):5611–5616. doi: 10.1128/jvi.64.11.5611-5616.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klenerman P., Meier U. C., Phillips R. E., McMichael A. J. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur J Immunol. 1995 Jul;25(7):1927–1931. doi: 10.1002/eji.1830250720. [DOI] [PubMed] [Google Scholar]
- Klenerman P., Rowland-Jones S., McAdam S., Edwards J., Daenke S., Lalloo D., Köppe B., Rosenberg W., Boyd D., Edwards A. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature. 1994 Jun 2;369(6479):403–407. doi: 10.1038/369403a0. [DOI] [PubMed] [Google Scholar]
- Kündig T. M., Bachmann M. F., DiPaolo C., Simard J. J., Battegay M., Lother H., Gessner A., Kühlcke K., Ohashi P. S., Hengartner H. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science. 1995 Jun 2;268(5215):1343–1347. doi: 10.1126/science.7761853. [DOI] [PubMed] [Google Scholar]
- Lehmann-Grube F., Assmann U., Löliger C., Moskophidis D., Löhler J. Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. J Immunol. 1985 Jan;134(1):608–615. [PubMed] [Google Scholar]
- Levy J. A., Mackewicz C. E., Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today. 1996 May;17(5):217–224. doi: 10.1016/0167-5699(96)10011-6. [DOI] [PubMed] [Google Scholar]
- Matloubian M., Concepcion R. J., Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol. 1994 Dec;68(12):8056–8063. doi: 10.1128/jvi.68.12.8056-8063.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McAdam S., Klenerman P., Tussey L., Rowland-Jones S., Lalloo D., Phillips R., Edwards A., Giangrande P., Brown A. L., Gotch F. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J Immunol. 1995 Sep 1;155(5):2729–2736. [PubMed] [Google Scholar]
- McChesney M. B., Oldstone M. B. Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. Annu Rev Immunol. 1987;5:279–304. doi: 10.1146/annurev.iy.05.040187.001431. [DOI] [PubMed] [Google Scholar]
- Meier U. C., Klenerman P., Griffin P., James W., Köppe B., Larder B., McMichael A., Phillips R. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science. 1995 Nov 24;270(5240):1360–1362. doi: 10.1126/science.270.5240.1360. [DOI] [PubMed] [Google Scholar]
- Moskophidis D., Battegay M., Bruendler M. A., Laine E., Gresser I., Zinkernagel R. M. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J Virol. 1994 Mar;68(3):1951–1955. doi: 10.1128/jvi.68.3.1951-1955.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moskophidis D., Battegay M., van den Broek M., Laine E., Hoffmann-Rohrer U., Zinkernagel R. M. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J Gen Virol. 1995 Feb;76(Pt 2):381–391. doi: 10.1099/0022-1317-76-2-381. [DOI] [PubMed] [Google Scholar]
- Moskophidis D., Laine E., Zinkernagel R. M. Peripheral clonal deletion of antiviral memory CD8+ T cells. Eur J Immunol. 1993 Dec;23(12):3306–3311. doi: 10.1002/eji.1830231237. [DOI] [PubMed] [Google Scholar]
- Moskophidis D., Lechner F., Hengartner H., Zinkernagel R. M. MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice. J Immunol. 1994 May 15;152(10):4976–4983. [PubMed] [Google Scholar]
- Moskophidis D., Lechner F., Pircher H., Zinkernagel R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature. 1993 Apr 22;362(6422):758–761. doi: 10.1038/362758a0. [DOI] [PubMed] [Google Scholar]
- Moskophidis D., Pircher H., Ciernik I., Odermatt B., Hengartner H., Zinkernagel R. M. Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo. J Virol. 1992 Jun;66(6):3661–3668. doi: 10.1128/jvi.66.6.3661-3668.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moskophidis D., Zinkernagel R. M. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J Virol. 1995 Apr;69(4):2187–2193. doi: 10.1128/jvi.69.4.2187-2193.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moss P. A., Rowland-Jones S. L., Frodsham P. M., McAdam S., Giangrande P., McMichael A. J., Bell J. I. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5773–5777. doi: 10.1073/pnas.92.13.5773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nowak M. A., Anderson R. M., McLean A. R., Wolfs T. F., Goudsmit J., May R. M. Antigenic diversity thresholds and the development of AIDS. Science. 1991 Nov 15;254(5034):963–969. doi: 10.1126/science.1683006. [DOI] [PubMed] [Google Scholar]
- Nowak M. A., Bangham C. R. Population dynamics of immune responses to persistent viruses. Science. 1996 Apr 5;272(5258):74–79. doi: 10.1126/science.272.5258.74. [DOI] [PubMed] [Google Scholar]
- Nowak M. A., May R. M. Coexistence and competition in HIV infections. J Theor Biol. 1992 Dec 7;159(3):329–342. doi: 10.1016/s0022-5193(05)80728-3. [DOI] [PubMed] [Google Scholar]
- Nowak M. A., May R. M. Mathematical biology of HIV infections: antigenic variation and diversity threshold. Math Biosci. 1991 Sep;106(1):1–21. doi: 10.1016/0025-5564(91)90037-j. [DOI] [PubMed] [Google Scholar]
- Nowak M. A., May R. M., Phillips R. E., Rowland-Jones S., Lalloo D. G., McAdam S., Klenerman P., Köppe B., Sigmund K., Bangham C. R. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature. 1995 Jun 15;375(6532):606–611. doi: 10.1038/375606a0. [DOI] [PubMed] [Google Scholar]
- Oldstone M. B., Salvato M., Tishon A., Lewicki H. Virus-lymphocyte interactions. III. Biologic parameters of a virus variant that fails to generate CTL and establishes persistent infection in immunocompetent hosts. Virology. 1988 Jun;164(2):507–516. doi: 10.1016/0042-6822(88)90565-x. [DOI] [PubMed] [Google Scholar]
- Pantaleo G., Menzo S., Vaccarezza M., Graziosi C., Cohen O. J., Demarest J. F., Montefiori D., Orenstein J. M., Fox C., Schrager L. K. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med. 1995 Jan 26;332(4):209–216. doi: 10.1056/NEJM199501263320402. [DOI] [PubMed] [Google Scholar]
- Rinaldo C. R., Jr, Beltz L. A., Huang X. L., Gupta P., Fan Z., Torpey D. J., 3rd Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. AIDS Res Hum Retroviruses. 1995 Apr;11(4):481–489. doi: 10.1089/aid.1995.11.481. [DOI] [PubMed] [Google Scholar]
- Rinaldo C., Huang X. L., Fan Z. F., Ding M., Beltz L., Logar A., Panicali D., Mazzara G., Liebmann J., Cottrill M. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol. 1995 Sep;69(9):5838–5842. doi: 10.1128/jvi.69.9.5838-5842.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scarlatti G., Leitner T., Hodara V., Jansson M., Karlsson A., Wahlberg J., Rossi P., Uhlén M., Fenyö E. M., Albert J. Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS. Immunol Lett. 1996 Jun;51(1-2):23–28. doi: 10.1016/0165-2478(96)02550-3. [DOI] [PubMed] [Google Scholar]
- Schenzle D. A model for AIDS pathogenesis. Stat Med. 1994 Oct 15;13(19-20):2067–2079. doi: 10.1002/sim.4780131916. [DOI] [PubMed] [Google Scholar]
- Selin L. K., Welsh R. M. Specificity and editing by apoptosis of virus-induced cytotoxic T lymphocytes. Curr Opin Immunol. 1994 Aug;6(4):553–559. doi: 10.1016/0952-7915(94)90140-6. [DOI] [PubMed] [Google Scholar]
- Thomsen A. R., Johansen J., Marker O., Christensen J. P. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J Immunol. 1996 Oct 1;157(7):3074–3080. [PubMed] [Google Scholar]
- Tishon A., Southern P. J., Oldstone M. B. Virus-lymphocyte interactions. II. Expression of viral sequences during the course of persistent lymphocytic choriomeningitis virus infection and their localization to the L3T4 lymphocyte subset. J Immunol. 1988 Feb 15;140(4):1280–1284. [PubMed] [Google Scholar]
- Tripp R. A., Sarawar S. R., Doherty P. C. Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene. J Immunol. 1995 Sep 15;155(6):2955–2959. [PubMed] [Google Scholar]
- Villarete L., Somasundaram T., Ahmed R. Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells. J Virol. 1994 Nov;68(11):7490–7496. doi: 10.1128/jvi.68.11.7490-7496.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995 Jan 12;373(6510):117–122. doi: 10.1038/373117a0. [DOI] [PubMed] [Google Scholar]
- Zinkernagel R. M., Hengartner H. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today. 1994 Jun;15(6):262–268. doi: 10.1016/0167-5699(94)90005-1. [DOI] [PubMed] [Google Scholar]
- Zinkernagel R. M., Moskophidis D., Kündig T., Oehen S., Pircher H., Hengartner H. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol Rev. 1993 Jun;133:199–223. doi: 10.1111/j.1600-065x.1993.tb01517.x. [DOI] [PubMed] [Google Scholar]
- de Boer R. J., Boerlijst M. C. Diversity and virulence thresholds in AIDS. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):544–548. doi: 10.1073/pnas.91.2.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van den Broek M. F., Müller U., Huang S., Aguet M., Zinkernagel R. M. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol. 1995 Aug;69(8):4792–4796. doi: 10.1128/jvi.69.8.4792-4796.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van den Broek M. F., Müller U., Huang S., Zinkernagel R. M., Aguet M. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev. 1995 Dec;148:5–18. doi: 10.1111/j.1600-065x.1995.tb00090.x. [DOI] [PubMed] [Google Scholar]